Schedule 13G filing

Whitefort Capital Management, LP disclosed a 8% stake in Arbutus Biopharma Corp (ABUS)

Schedule 13G · Filed Sep 4, 2026

Whitefort Capital Management, LP reported owning 8% of Arbutus Biopharma Corp (ABUS) (15,794,261 shares) in a Schedule 13G filed Sep 4, 2026.

A 13G is a passive stake: the holder does not plan to push for changes.

Stake

Arbutus Biopharma Corp

Stake

8% stake

Share this trade

From a public Schedule 13G, linked above. Not investment advice, and not a recommendation to buy or sell.